98 related articles for article (PubMed ID: 26027734)
1. Structural Basis for Modulation of Quality Control Fate in a Marginally Stable Protein.
Brock KP; Abraham AC; Amen T; Kaganovich D; England JL
Structure; 2015 Jul; 23(7):1169-78. PubMed ID: 26027734
[TBL] [Abstract][Full Text] [Related]
2. Adding structural information to the von Hippel-Lindau (VHL) tumor suppressor interaction network.
Leonardi E; Murgia A; Tosatto SC
FEBS Lett; 2009 Nov; 583(22):3704-10. PubMed ID: 19878677
[TBL] [Abstract][Full Text] [Related]
3. Combination of multiple alignment analysis and surface mapping paves a way for a detailed pathway reconstruction--the case of VHL (von Hippel-Lindau) protein and angiogenesis regulatory pathway.
Sikora S; Godzik A
Protein Sci; 2004 Mar; 13(3):786-96. PubMed ID: 14767077
[TBL] [Abstract][Full Text] [Related]
4. Genetic characterization and protein stability analysis of a Chinese family with Von Hippel-Lindau disease.
Gao Y; Huang YP; Tu XA; Luo DS; Wang DH; Qiu SP; Xiang P; Li WQ; Jan R; Zhang YY; Sun XZ; Deng CH
Chin Med J (Engl); 2013; 126(19):3690-3. PubMed ID: 24112165
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
6. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
7. Comparative sequence analysis of the VHL tumor suppressor gene.
Woodward ER; Buchberger A; Clifford SC; Hurst LD; Affara NA; Maher ER
Genomics; 2000 May; 65(3):253-65. PubMed ID: 10857749
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular features of familial and sporadic cases of von Hippel-Lindau disease from Mexico.
Chacon-Camacho OF; Rodriguez-Dennen F; Camacho-Molina A; Rasmussen A; Alonso-Vilatela E; Zenteno JC
Clin Exp Ophthalmol; 2010 Apr; 38(3):277-83. PubMed ID: 20447124
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions.
Knauth K; Bex C; Jemth P; Buchberger A
Oncogene; 2006 Jan; 25(3):370-7. PubMed ID: 16261165
[TBL] [Abstract][Full Text] [Related]
10. Simulation of the mutation F76del on the von Hippel-Lindau tumor suppressor protein: mechanism of the disease and implications for drug development.
Limaverde-Sousa G; Barreto Ede A; Ferreira CG; Casali-da-Rocha JC
Proteins; 2013 Feb; 81(2):349-63. PubMed ID: 23011899
[TBL] [Abstract][Full Text] [Related]
11. Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking.
Kim DS; Choi YB; Han BG; Park SY; Jeon Y; Kim DH; Ahn ER; Shin JE; Lee BI; Lee H; Hong KM; Kim SY
Oncogene; 2011 Dec; 30(48):4780-90. PubMed ID: 21625219
[TBL] [Abstract][Full Text] [Related]
12. A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma.
D'Elia AV; Grimaldi F; Pizzolitto S; De Maglio G; Bregant E; Passon N; Franzoni A; Verrienti A; Tamburrano G; Durante C; Filetti S; Fogolari F; Russo D; Damante G
Clin Endocrinol (Oxf); 2013 Mar; 78(3):391-7. PubMed ID: 22946750
[TBL] [Abstract][Full Text] [Related]
13. Novel human pathological mutations. Gene symbol: VHL. Disease: Von Hippel-Lindau syndrome.
Ellison J
Hum Genet; 2010 Apr; 127(4):477. PubMed ID: 21488287
[No Abstract] [Full Text] [Related]
14. Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome.
Gaal J; van Nederveen FH; Erlic Z; Korpershoek E; Oldenburg R; Boedeker CC; Kontny U; Neumann HP; Dinjens WN; de Krijger RR
J Clin Endocrinol Metab; 2009 Nov; 94(11):4367-71. PubMed ID: 19808854
[TBL] [Abstract][Full Text] [Related]
15. Germline VHL gene mutations in three Serbian families with von Hippel-Lindau disease.
Stanojevic BR; Lohse P; Neskovic GG; Damjanovic SM; Novkovic TB; Jovanovic-Cupic SP; Dimitrijević BB
Neoplasma; 2007; 54(5):402-6. PubMed ID: 17688370
[TBL] [Abstract][Full Text] [Related]
16. Digging for Buried Amino Acids Unearths New Protein Quality Control Treasure.
Jones RD; Gardner RG
Structure; 2015 Jul; 23(7):1151-2. PubMed ID: 26153878
[TBL] [Abstract][Full Text] [Related]
17. von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms.
Calzada MJ; Esteban MA; Feijoo-Cuaresma M; Castellanos MC; Naranjo-Suárez S; Temes E; Méndez F; Yánez-Mo M; Ohh M; Landázuri MO
Cancer Res; 2006 Feb; 66(3):1553-60. PubMed ID: 16452212
[TBL] [Abstract][Full Text] [Related]
18. Drosophila von Hippel-Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity.
Aso T; Yamazaki K; Aigaki T; Kitajima S
Biochem Biophys Res Commun; 2000 Sep; 276(1):355-61. PubMed ID: 11006129
[TBL] [Abstract][Full Text] [Related]
19. Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.
Lutz MS; Burk RD
Cancer Res; 2006 Jul; 66(14):6903-7. PubMed ID: 16849532
[TBL] [Abstract][Full Text] [Related]
20. In silico investigation of PHD-3 specific HIF1-α proline 567 hydroxylation: a new player in the VHL/HIF-1α interaction pathway?
Minervini G; Masiero A; Moro S; Tosatto SC
FEBS Lett; 2013 Sep; 587(18):2996-3001. PubMed ID: 23886708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
